Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia, T-Cell × mogamulizumab × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Mycosis Fungoides 6 Lymphoma, T-Cell, Cutaneous 5 Sezary Syndrome 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma 1 Leukemia, T-Cell 1

Interventions

mogamulizumab 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06698003 2026-03-05

A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Leukemia, T-Cell, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡